The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Retinoids in cancer therapy.
Abstract
PURPOSE: Recent reports of the dramatic antitumor effect of all-trans retinoic acid (RA) in patients with acute promyelocytic leukemia (APL) have generated renewed enthusiasm for clinical studies of retinoids for oncologic therapeutic indications. Here we provide an overview of relevant aspects of retinoid physiology and molecular biology, review preclinical studies indicating antitumor activity for retinoids, and summarize the current status of clinical investigations of retinoid use for the treatment of adult and pediatric tumors. DESIGN: The published literature was reviewed with attention to areas of retinoid research that would shed insight into the oncologic uses of retinoids. RESULTS: Retinoids play critical roles during normal fetal development and induce differentiation (and/or growth inhibition) in a variety of tumor-cell lines. Retinoid effects seem to result from changes in gene expression mediated via specific nuclear receptors (termed retinoic acid receptors, RAR-alpha, -beta, and -gamma), and a specific chromosomal translocation involving the RAR-alpha gene occurs in APL patients. In addition to the very high clinical response rate for RA in patients with APL, significant clinical responses have been observed for patients with cutaneous T-cell malignancies, juvenile chronic myelogenous leukemia, and dermatologic malignancies. Additionally, the combination of 13-cis-retinoic acid (cRA) with interferon alpha (IFN alpha) has produced high objective response rates for patients with squamous cell carcinomas of the head and neck and of the cervix. CONCLUSIONS: The antitumor activity demonstrated for retinoids (especially RA) alone and in combination with other agents supports the need for targeted phase II trials to define the spectrum of responsive tumors and for laboratory studies to further delineate the biologic mechanisms associated with therapeutic responses. High priority should then be given to phase III trials to delineate optimal strategies for improving outcome by combining retinoid-based treatments with conventional chemotherapy and radiotherapy regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–249 of 249
Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes
Sidell, N., & Ramsdell, F. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90183-9 · Cited by 53
Trinchieri, G., Rosen, M., & PERUSSIA, B. (1987) · Blood · doi:10.1182/blood.v69.4.1218.1218 · Cited by 51
Sacks, P. G., Oke, V., Amos, B., Vasey, T., & Lotan, R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440530 · Cited by 49
Stüttgen, G. (1975) · PubMed · Cited by 48
Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer.
Wakefield, L. M., & Sporn, M. B. (1990) · PubMed · Cited by 48
Cytostatic Effects of Suramin on Prostate Cancer Cells Cultured from Primary Tumors
Peehl, D. M., Wong, S. T., & Stamey, T. A. (1991) · The Journal of Urology · doi:10.1016/s0022-5347(17)38408-2 · Cited by 47
Long-Term Retinoid Therapy Is Needed for Maintenance of Cancer Chemopreventive Effect
Peck, G. L. (2009) · Dermatologica · doi:10.1159/000248870 · Cited by 45
Fontana, J. A., Miranda, D., & Burrows‐Mezu, A. (1990) · PubMed · Cited by 45
Gallagher, R. E., Said, F., Pua, I., Papenhausen, P. R., Paietta, E. M., & Wiernik, P. H. (1989) · PubMed · Cited by 45
Independent regulation of HNF‐1 alpha and HNF‐1 beta by retinoic acid in F9 teratocarcinoma cells.
Kuo, C. J., Mendel, D. B., Hansen, L. P., & Crabtree, G. R. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07759.x · Cited by 44
Phase II trial of 13-cis-retinoic acid in metastatic breast cancer
Cassidy, J., Lippman, M. E., Lacroix, A., et al. (1982) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(82)90239-5 · Cited by 43
Suedhoff, T., Birckbichler, P. J., Lee, K. N., Conway, E., & Patterson, M. K. (1990) · PubMed · Cited by 43
cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro
Lawrence, H. J., Conner, K., Kelly, M., Haussler, M. R., Wallace, P., & Bagby, G. J. (1987) · Blood · doi:10.1182/blood.v69.1.302.302 · Cited by 43
Hoffman, S. J., & Robinson, W. A. (1988) · American Journal of Hematology · doi:10.1002/ajh.2830280214 · Cited by 42
Imaizumi, M., & Breitman, T. R. (1986) · Blood · doi:10.1182/blood.v67.5.1273.1273 · Cited by 42
All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
Crouch, G. D., & Helman, L. J. (1991) · PubMed · Cited by 40
Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid
Bonhomme‐Faivre, L., Fredj, G., Averous, S., Szekely, A. M., Ecstein, E., Trumbic, B., Meyer, P., Lang, J. M., Misset, J. L., & Jasmin, C. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057916 · Cited by 39
Chomienne, C., Balitrand, N., Degos, L., & Abita, J. (1986) · Leukemia Research · doi:10.1016/0145-2126(86)90265-1 · Cited by 37
Momparler, R. L., Doré, B. T., & Momparler, L. F. (1990) · Cancer Letters · doi:10.1016/0304-3835(90)90086-d · Cited by 37
Lotan, R., Sacks, P. G., Lotan, D., et al. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400217 · Cited by 37
Abrahm, J. L., Besa, E., Hyzinski, M., Finan, J. B., & Nowell̀, P. C. (1986) · Blood · doi:10.1182/blood.v67.5.1323.1323 · Cited by 37
Higuchi, T., Hannigan, G. E., Malkin, D. M., Yeger, H., & Williams, B. R. G. (1991) · PubMed · Cited by 36
Hassan, H. T., & Rees, J. K. H. (1988) · Hematological Oncology · doi:10.1002/hon.2900060107 · Cited by 36
Lando, M., Abemayor, E., Verity, M. A., & Sidell, N. (1990) · PubMed · Cited by 33
Adjuvant effect of vitamin A palmitate and analogs on cell-mediated immunity.
Athanassiades, T. J. (1981) · PubMed · Cited by 33
Hirschel-Scholz, S., Siegenthaler, G., & Saurat, J. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01349.x · Cited by 33
Woodworth, C. D., Mossman, B. T., & Craighead, J. E. (1983) · PubMed · Cited by 32
Robertson, K. A., Mueller, L., & Collins, S. (1991) · Blood · doi:10.1182/blood.v77.2.340.340 · Cited by 32
Wathne, K. O., Norum, K. R., Smeland, E. B., & Blomhoff, R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68360-7 · Cited by 31
Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck
Lippman, S. M., Garewal, H. S., & Meyskens, F. L. (1989) · Preventive Medicine · doi:10.1016/0091-7435(89)90045-5 · Cited by 31
Expression of the α and β Retinoic Acid Receptors in Skin
Rees, J. L., & Redfern, C. P. F. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12284435 · Cited by 30
High‐dose retinol in children with acute myelogenous leukemia in remission
Lie, S. O., Wathne, K., Petersen, L. B., Slørdahl, S. H., & Norum, K. R. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb00856.x · Cited by 30
Nakamaki, T., Sakashita, A., Sano, M., Hino, K., Suzuki, K., Tomoyasu, S., Tsuruoka, N., Honma, Y., & Hozumi, M. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb02262.x · Cited by 28
Chemoprevention of Head and Neck Cancer: Potential Use of Retinoids
Hong, W. K., & Doos, W. G. (1985) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(20)31856-9 · Cited by 28
Cope, F. O., & Wille, J. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5590 · Cited by 27
Effects of retinoids on growth and dissemination of malignant tumours: Immunological considerations
Eccles, S. A. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90623-9 · Cited by 27
Sacks, P. G., Oke, V., Vasey, T., Calkins, D. P., & Terry, N. H. A. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041440209 · Cited by 26
Retinoic acid (RA): An inhibitor of 5α-reductase in human prostatic cancer cells
Halgunset, J., Sunde, A. L., & Lundmo, P. I. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90405-5 · Cited by 25
Colombat, P., Santini, V., Krefft, D. J., Bredmond, J. L., & Löwenberg, B. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08045.x · Cited by 23
Effect of retinoids on xenotransplanted human mammary carcinoma cells in athymic mice.
Halter, S. A., Fraker, L. D., Adcock, D. M., & Vick, S. (1988) · PubMed · Cited by 22
Interactions of retinoic acid and androgens in human prostatic tissue
Jutley, J. K., Reaney, S., Kelleher, J., & Whelan, P. (1990) · The Prostate · doi:10.1002/pros.2990160404 · Cited by 18
Sampi, K., Honma, Y., Hozumi, M., & Sakurai, M. (1985) · Leukemia Research · doi:10.1016/0145-2126(85)90039-6 · Cited by 18
Lacroix, A., Doskas, C., & Bhat, P. V. (1990) · PubMed · Cited by 16
Hassan, H. T., & Rees, J. K. H. (1989) · Hematological Oncology · doi:10.1002/hon.2900070606 · Cited by 15
Pharmacology of topical retinoids
Shroot, B. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70230-2 · Cited by 14
Bell, B. A., Findley, H. W., Krischer, J., Whitehead, V. M., Holbrook, T., Haggard, M. E., Konrad, P. N., Hensley, M. L., & Ragab, A. H. (1991) · Journal of Immunotherapy · doi:10.1097/00002371-199104000-00001 · Cited by 11
Hemmi, H., Nakamura, T., SHIMIZU, Y., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.12.952 · Cited by 9
Soppi, E. T., Robért, K., & Gahrton, G. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb00871.x · Cited by 4
Prabhala (1991) · doi:10.1002/1097-0142(19910315)67:6<1556::aid-cncr2820670616>3.0.co;2-o
Cited by
Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., & Hong, W. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280306 · Cited by 2,211
He, L.-Z., Figueiredo-Pontes, L. L., Rego, E. M., & Pandolfi, P. P. (2015) · Encyclopedia of Cancer · doi:10.1007/978-3-662-46875-3_63 · Cited by 766
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 557
Role of PML in Cell Growth and the Retinoic Acid Pathway
Gang Wang, Z., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., & Paolo Pandolfi, P. (1998) · Science · doi:10.1126/science.279.5356.1547 · Cited by 517
Nuclear Receptor/AP-1 Interaction*
PFAHL, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-651 · Cited by 446
Metadata
- Authors
- Smith, M. A., Parkinson, D. R., Cheson, B. D., & Friedman, M. A.
- Venue
- Journal of Clinical Oncology
- Published
- 1992-05
- Volume
- 10
- Issue
- 5
- Pages
- 839-864
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2168731357
- Cited by
- 486
- References
- 249
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.